| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 23 Jul 2025 | 42 | 63% | 13% | 24% | 26% |
| 01 Jul 2024 - 31 Dec 2024 | 21 Jan 2025 | 42 | 46% | 17% | 37% | 66% |
| 01 Jan 2024 - 30 Jun 2024 | 22 Jul 2024 | 26 | 64% | 21% | 15% | 46% |
| 01 Jul 2023 - 31 Dec 2023 | 23 Jan 2024 | 20 | 77% | 14% | 9% | 55% |
| 01 Jan 2023 - 30 Jun 2023 | 25 Jul 2023 | 18 | 82% | 10% | 8% | 41% |
| 01 Jul 2022 - 31 Dec 2022 | 23 Jan 2023 | 16 | 84% | 10% | 6% | 26% |
| 01 Jan 2022 - 30 Jun 2022 | 21 Jul 2022 | 20 | 81% | 9% | 10% | 30% |
| 01 Jul 2021 - 31 Dec 2021 | 21 Jan 2022 | 18 | 81% | 8% | 11% | 34% |
| 01 Jan 2021 - 30 Jun 2021 | 26 Jul 2021 | 23 | 80% | 6% | 14% | 43% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
90 days payment from date of invoice
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
The main point of contact for disputes is the Global Shared Services Centre(locations in Slovakia and India) . When an invoice is rejected an email is sent indicating the invoice number and reason for rejection. To resolve a dispute, the supplier is required to provide any missing information or a corrected invoice. IQVIA follows a strict no PO no pay policy. The PO number is communicated by IQVIA's procurement team at the time of placing the order.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
IQVIA Biotech Ltd, registered in the UK, operates as a specialised contract research organisation supporting biotech companies through clinical development. It provides full-service clinical trial delivery, from trial design and implementation through to launch and commercialisation, with therapeutic expertise across oncology, cell and gene therapy, central nervous system conditions, cardiovascular, renal and metabolic disease, dermatology and internal medicine. The company positions itself as a strategic partner helping smaller biotech firms advance treatments toward patients while reporting results to investors and regulators. Its SIC classification confirms research and experimental development in biotechnology, consistent with its clinical research services role within the wider IQVIA group of pharmaceutical services companies.
Generated from the company's website and Companies House records. Sources: novellaclinical.com